trying to get first doses into people. if we could get first doses into people and get the majority of our population to that immune state, we could certainly begin to stem the tide. i think boosters, when you talk about boosters, we have to think about the immunocompromised, people who have cancer, chemotherapeutic agents, transplant patients, organ transplant patients. ha we don t know even though these patients may receive the full dose of the vaccine, we really don t know if they reach full immunity because their immune systems are suppressed and those particular patients might benefit, especially from a third dose at this point. and to that point, i just want to read you this tweet interest dr. jonathan reiner who is a frequent guest on cnn, writes i gave a kidney transplant patient with no covid antibodies a prescription for a booster dose and three pharmacies refused to give him the shot. cdc needs to move forward with
sufferers, sometimes the symptoms are because of the treatment. that s a great question, the first person to ask that, and absolutely. chemotherapeutic agents can be quite toxic to people, make them not feel well. at some point you say we don t have confidence they ll do anything so that s part of it. pulling back some treatment, adding some others. it s worth pointing out that for a lot of women out there, you re right, cancer is not one does, but the five-year survival rate for breast cancer across the board about 88%, ten-year survival rate 80%. okay. so we have there are some good numbers. just to remind our viewers, when we talk about cancer, we don t talk about cures, we talk about survival rates. and they re high. women today watching this story will say there s some progress being made in how we deal with cancer and the outcomes as a result. i think that s some good news. sanjay, what s the best take-away from this? i thought about that a lot. i think elizabeth